Company
Aviceda Therapeutics
The world leader in glyco-immune checkpoint therapeutics
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
We develop novel therapies to improve the lives of patients with immune-mediated diseases, leading with Macular Degeneration, a major cause of blindness.
Loading relationship preview